Prohibitin Protects Pulmonary Microvascular Endothelial Cells Against Cigarette Smoke Extract-Induced Cell Apoptosis and Inflammation
Yating Peng,Wei Cheng,Jiaxi Duan,Yiyang Zhao,Zijing Zhou,Aiyuan Zhou,Minhua Deng,Hong Peng,Ruoyun Ouyang,Yan Chen,Ping Chen
DOI: https://doi.org/10.2147/COPD.S345058
2022-03-29
International Journal of COPD
Abstract:Yating Peng, 1– 3 Wei Cheng, 1– 3 Jiaxi Duan, 1– 3 Yiyang Zhao, 1– 3 Zijing Zhou, 1– 3 Aiyuan Zhou, 1– 3 Minhua Deng, 1– 4 Hong Peng, 1– 3 Ruoyun Ouyang, 1– 3 Yan Chen, 1– 3 Ping Chen 1– 3 1 Department of Pulmonary and Critical Care Medicine, Second Xiang Ya Hospital, Central South University, Changsha, Hunan, 410011, People's Republic of China; 2 Institute of Respiratory Disease, Central South University, Changsha, Hunan, 410011, People's Republic of China; 3 Hunan Centre for Diagnosis and Treatment of Respiratory Disease, Changsha, Hunan, 410011, People's Republic of China; 4 Department of Respiratory, PLA Rocket Force Characteristic Medical Center, Beijing, 100088, People's Republic of China Correspondence: Ping Chen, Email Background: Prohibitin has been identified to play roles in cell survival and apoptosis. Here, this study aimed to clarify the role of prohibitin in cigarette smoke extract (CSE)-induced endothelial cell apoptosis. Methods: The protein level of prohibitin was assessed by Western blot in lung tissues from emphysema and control mice. CSE-induced human pulmonary microvascular endothelial cells (hPMECs) were applied to mimic smoke-related cell apoptosis in vitro. Prohibitin was overexpressed in hPMECs with or without CSE. Mitochondrial function was analyzed by JC-1 staining and ATP assay kits. Oxidative stress was assessed by flow cytometry, fluorescence staining and immunocytochemistry. Apoptosis was analyzed by flow cytometry, Western blot and caspase-3 activity assays. In addition, the expression of inflammatory markers was assessed by Western blot and real-time polymerase chain reaction (PCR). The secretion of inflammatory cytokines was measured by ELISA. Results: Prohibitin was downregulated in emphysema mouse tissues compared with control experiments. Consistently, CSE inhibited both the protein and RNA levels of prohibitin in hPMECs in a dose-dependent manner. Gain-of-function experiments indicated that CSE induced collapse of mitochondrial membrane potential (MMP) and loss of ATP, while prohibitin improved mitochondrial function. CSE induced robust ROS production and oxidative DNA damage, while prohibitin decreased this damage. Upregulation of prohibitin protected the apoptosis of hPMECs from CSE. Overexpression of prohibitin significantly reduced the levels of the main proinflammatory cytokines. Finally, prohibitin inhibited nuclear factor-kappa B (NF-κB) p65 accumulation and IκBα degradation induced by CSE. Conclusion: The current findings suggest that CSE-mediated mitochondrial dysfunction, oxidative stress, cell apoptosis and inflammation in hPMECs were reduced by overexpression of prohibitin. We identified prohibitin as a novel regulator of endothelial cell apoptosis and survival in the context of CSE exposure. Keywords: prohibitin, hPMECs, CSE, apoptosis, mitochondrial, inflammation Chronic obstructive pulmonary disease (COPD) is a progressive destructive lung disease with persistent chronic inflammation characterized by airflow limitation and severe respiratory failure. 1 Cigarette smoke (CS) exposure is identified as a major risk factor for COPD. As COPD is frequently exacerbated and often associated with severe complications, the clinical prognosis of COPD patients remains poor. 2 Early research into the pathogenesis of COPD focused on the contributions of injury to the extracellular matrix and pulmonary epithelial cells. There is a critical interdependence between alveolar epithelial and microvascular endothelial cells (ECs) in the maintenance of airspace structure, and loss of ECs within the lung directly contributes to emphysematous remodeling. 3,4 More recently, CS-induced endothelial apoptosis has been linked to pulmonary lesions in COPD (especially emphysema) and systemic comorbidities, including atherosclerosis, pulmonary hypertension, and chronic renal injury. 4 In addition to apoptosis, persistent inflammation, protease–antiprotease imbalance, and oxidative stress in ECs also contribute to COPD. 5–7 Chronic smoking exposes the respiratory tree and lungs to reactive oxygen species (ROS), resulting in oxidative stress and injury. Long-term exposure to CS increases ROS levels, decreases total antioxidant capacity, and interferes with DNA repair capacity, which eventually induces oxidative DNA damage. 8,9 Simultaneously, compared with control subjects, COPD patients experience an overall heightened state of systemic inflammation reflected by biomarkers, such as cytokines and nitric oxide, which further increase with exacerbations. 8 Prohibitin is a highly conserved -Abstract Truncated-
respiratory system